- Top Workplaces
- United Therapeutics Corporation
United Therapeutics Corporation
United Therapeutics Corporation focuses on the strength of a balanced, value-creating biotechnology model. We are confident in our future thanks to our fundamental attributes, namely our obsession with quality and innovation, the power of our brands, our entrepreneurial culture and our bioinformatics leadership. We also believe that our determination to be responsible citizens – having a positive impact on patients, the environment and society – will sustain our success in the long term.
Through our wholly-owned subsidiary, Lung Biotechnology PBC, we are focused on addressing the acute national shortage of transplantable lungs and other organs with a variety of technologies that either delay the need for such organs or expand the supply. Lung Biotechnology is the first public benefit corporation subsidiary of a public biotechnology or pharmaceutical company.
Through our wholly-owned subsidiary, Lung Biotechnology PBC, we are focused on addressing the acute national shortage of transplantable lungs and other organs with a variety of technologies that either delay the need for such organs or expand the supply. Lung Biotechnology is the first public benefit corporation subsidiary of a public biotechnology or pharmaceutical company.
Purpose
To one day find a cure for pulmonary arterial hypertension.
Mission
United Therapeutics Corporation focuses on the strength of a balanced, value-creating biotechnology model. We are confident in our future thanks to our fundamental attributes, namely our obsession with quality and innovation, the power of our brands, our entrepreneurial culture and our bioinformatics leadership. We also believe that our determination to be responsible citizens – having a positive impact on patients, the environment and society – will sustain our success in the long term.
Through our wholly-owned subsidiary, Lung Biotechnology PBC, we are focused on addressing the acute national shortage of transplantable lungs and other organs with a variety of technologies that either delay the need for such organs or expand the supply. Lung Biotechnology is the first public benefit corporation subsidiary of a public biotechnology or pharmaceutical company.
Through our wholly-owned subsidiary, Lung Biotechnology PBC, we are focused on addressing the acute national shortage of transplantable lungs and other organs with a variety of technologies that either delay the need for such organs or expand the supply. Lung Biotechnology is the first public benefit corporation subsidiary of a public biotechnology or pharmaceutical company.
Additional Culture Details
United Therapeutics prides itself on being unique and different, and the perfect example of that is that our employees refer to each other as Unitherians! We express our uniqueness in several ways, but one example is through our Annual Reports which have received many International Awards. Past reports have been featured as a comic book, a tablecloth of UT elements, a children's book, an airplane, and one year the annual report was an event put to music! However, if you could only choose one word to describe our Unitherian culture, it might well be purpose. UT was founded on a single purpose - to one day find a cure for pulmonary arterial hypertension. Our sense of purpose is what makes our company a stimulating place to work. A place that engages our minds, our hearts, and our most spirited efforts. Our sense of purpose transforms what we do from work into mission, occupation into vocation, achievement into success.
Recent Awards
Company Snapshots
